Assessment of treatment in melasma by picosecond laser at 108 Military Central Hospital

Abstract

Background: Melasma is a common acquired, chronic hypermelanosis, more common in women and dark skin types, less dangerous but greatly affects aesthetics. The picosecond laser have been used with good effectiveness on melasma. Objective: To evaluate the efficacy and safety of a picosecond laser (Picoplus, Lutronic, Korea) on patients with melasma. Subject and method: We conducted a comparative longitudinal descriptive study in 58 dermal and mixed melasma patients (100% females), middle-aged, with initial severe MASI underwent treatments in 108 Military Central Hospital from 7/2017 to 12/2018 with picosecond laser. Result: Good/excellent improvement 28.9%, fair 42.2% after 8 treatment sessions. All most patient was no side effect, only 3.4% patients had temporary burning sensation. Conclusion: Treatment of melasma using a picosecond laser is an effective and safe method. However, the disadvantage of the method is the multistage procedure.